Case Report
Accepted on 13 Jan 2026
Bevacizumab Combined with Chemotherapy Followed by PARP Inhibitor Maintenance Therapy in POLE-Mutated Primary Fallopian Tube Carcinoma: A Case of Precision Treatment in a Rare Gynecologic Malignancy
- 133 views
Case Report
Accepted on 13 Jan 2026
Original Research
Accepted on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Editorial
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Systematic Review
Published on 13 Jan 2026
Mini Review
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Opinion
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Editorial
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Study Protocol
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026
Editorial
Published on 13 Jan 2026
Original Research
Published on 13 Jan 2026